Drug intelligence / Profile preview

polythiazide

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Polythiazide is a thiazide diuretic used primarily for the management of hypertension and treatment of edema associated with conditions such as congestive heart failure, hepatic cirrhosis, corticosteroid and estrogen therapy, and various forms of renal dysfunction. It acts by inhibiting the solute carrier family 12 member 3 (Na+/Cl- cotransporter) in the distal convoluted tubule of the nephron in the kidney. This inhibition reduces reabsorption of sodium and chloride ions, leading to increased excretion of these ions along with water. The resulting diuresis helps decrease blood volume and lower blood pressure. Polythiazide may also increase potassium excretion via a sodium-potassium exchange mechanism. Its antihypertensive effect may be partially mediated through actions on carbonic anhydrases or large-conductance calcium-activated potassium channels in smooth muscle[1][2][6][8].

Brand names
ReneseMinizideRenese-R
02

Targets

KCNMA1 (Calcium-activated potassium channel subfamily M alpha member 1)CA (Carbonic anhydrase)SLC12A3 (Thiazide-sensitive sodium-chloride cotransporter)

Beyond the preview

Go deeper on polythiazide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polythiazide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call